Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
11.30
+0.04 (0.36%)
At close: Jun 27, 2025, 4:00 PM
11.22
-0.08 (-0.71%)
After-hours: Jun 27, 2025, 7:44 PM EDT
Verve Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$14.57
Upside
+28.94%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy → Hold Downgrades $20 → $14 | Buy → Hold | Downgrades | $20 → $14 | +19.47% | Jun 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $14 | Strong Buy → Hold | Downgrades | $14 | +19.47% | Jun 18, 2025 |
| LifeSci Capital | LifeSci Capital | Buy → Hold Downgrades $12 | Buy → Hold | Downgrades | $12 | +6.19% | Jun 18, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $28 → $11 | Strong Buy → Hold | Downgrades | $28 → $11 | -2.65% | Jun 18, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 17, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $39 → $13 | Strong Buy → Hold | Downgrades | $39 → $13 | +15.04% | Jun 17, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Apr 15, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $18 → $24 | Strong Buy | Maintains | $18 → $24 | +112.39% | Apr 15, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $32 → $39 | Strong Buy | Maintains | $32 → $39 | +245.13% | Apr 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $25 | Strong Buy | Maintains | $15 → $25 | +121.24% | Apr 14, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +32.74% | Mar 25, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $17 → $15 | Buy | Maintains | $17 → $15 | +32.74% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +32.74% | Feb 28, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $29 → $32 | Strong Buy | Maintains | $29 → $32 | +183.19% | Nov 6, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $20 → $17 | Buy | Maintains | $20 → $17 | +50.44% | Nov 6, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.